GlassScriptPhysician profile
Marcella M Nachmann
NPI 1265479547
$6,639.18
in general payments reported to CMS, 2019-2025
27 companies · $814 in 2025
The $814 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $127 · 2021: $3,087 · 2022: $310 · 2023: $1,017 · 2024: $767 · 2025: $814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,373 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,372.62 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $125.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,721.90 | 2021-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $1,444.55 | 2021-2025 | Interstim, Altaviva |
| Astellas Pharma US INC | $820.47 | 2019-2025 | Veozah, Xtandi |
| Bluewind Medical | $189.83 | 2024 | Revi |
| Boston Scientific Corporation | $179.69 | 2021-2025 | Ams 700, Solyx Sis System |
| Sumitomo Pharma America, INC. | $178.46 | 2024-2025 | Gemtesa |
| Allergan, INC. | $160.26 | 2019-2021 | |
| Coloplast Corp | $158.27 | 2019-2025 | |
| Neotract INC. | $153.91 | 2019 | |
| Calyxo, INC. | $149.78 | 2025 | Cvac Aspiration System |
| Janssen Biotech, INC. | $93.06 | 2019-2021 | |
| Pfizer INC. | $79.24 | 2019-2025 | |
| Myovant Sciences INC. | $40.93 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $40.22 | 2019-2021 | |
| Antares Pharma, INC. | $29.00 | 2021-2025 | Xyosted |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $26.33 | 2021 | |
| Trevena, INC. | $19.63 | 2021 | |
| Laborie Medical Technologies Corp. | $18.66 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Novartis Pharmaceuticals Corporation | $17.66 | 2025 | |
| Dendreon Pharmaceuticals LLC | $17.14 | 2025 | Provenge |
| Clinigen, INC. | $16.34 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $14.77 | 2020 | |
| Ferring Pharmaceuticals INC. | $14.57 | 2019 | |
| Urovant Sciences INC | $14.32 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $14.00 | 2025 | Bard Urinary Drainage Bag |
| Metuchen Pharmaceuticals | $13.48 | 2020 | |
| Clarus Therapeutics INC. | $12.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcella Nachmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.